发明名称 |
Injectable ibuprofen formulation |
摘要 |
The present invention provides a pharmaceutical composition comprising an aqueous solution of an ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition. The invention further provides a method of treating a condition chosen from pain, inflammation, fever, and/or patent ductus arteriosis, comprising administering to a patient in need thereof an effective amount of an aqueous solution a ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 5 mg/mL without undergoing a phase transition, as well as a method for manufacturing the composition. |
申请公布号 |
US9072710(B2) |
申请公布日期 |
2015.07.07 |
申请号 |
US201213422761 |
申请日期 |
2012.03.16 |
申请人 |
Cumberland Pharmaceuticals Inc. |
发明人 |
Pavliv Leo;Vila Andrew |
分类号 |
A61K31/192 |
主分类号 |
A61K31/192 |
代理机构 |
Davidson, Davidson & Kappel LLC |
代理人 |
Davidson, Davidson & Kappel LLC |
主权项 |
1. A pharmaceutical composition comprising an aqueous solution of ibuprofen, water for injection, and an ibuprofen solubilizing agent consisting of tribasic sodium phosphate, the aqueous solution being at a pH from 6.8 to 7.8, the molar ratio of tribasic sodium phosphate to ibuprofen being greater than 0.65:1to about 0.9:1, such that the ibuprofen in the solution remains soluble at concentrations from 100 mg/mL to 4 mg/mL without undergoing a phase transition, and the pharmaceutical composition is clear, colorless and suitable for intravenous administration. |
地址 |
Nashville TN US |